FindMyKOL
Clinical trialNCT04473261UnknownPhase 1/PHASE2Interventional

Efficacy of Iodine Complex Against COVID-19 Patients

SponsorSohaib AshrafEnrollment200Corona Virus InfectionCovid19SARS-CoV-2
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to measure the effect of Iodine complex in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan
  • Shaikh Zayed Hospital

    Lahore, Pakistan

    Muhammad Ahmad Imran, MBBSUzma Nasim, FCPS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Idoine ComplexIodine ComplexPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Jul 2020
Primary completion
15 Aug 2021
Completion
15 Oct 2021
Last update posted
7 Jul 2021
Registered enrollment
200
Registry id
NCT04473261

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.